Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study
Chunyan Lu,1 Yun Chen,2 Bin Zhang,2 Yu Chen,2 Fan Bai,2 Decai Chen1 1Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China; 2Lilly Suzhou Pharmaceutical Co. Ltd, Shanghai, China Abstract: Teriparatide is the first anabolic agent for osteoporosis, and t...
Saved in:
Main Authors: | Lu C, Chen Y, Zhang B, Bai F, Chen D |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/b9ac0f2e0dc640189aaaabb618b28cfd |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of osteoporosis with teriparatide: The Slovenian experience
by: Kocjan Tomaz, et al.
Published: (2021) -
Effects of teriparatide in Chinese and Caucasian women with osteoporosis: bridging study on efficacy
by: Xie Z, et al.
Published: (2019) -
Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study
by: Nishikawa A, et al.
Published: (2016) -
Serum uric acid is associated with lumbar spine bone mineral density in healthy Chinese males older than 50 years
by: Xiao J, et al.
Published: (2017) -
The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients
by: Wang Z, et al.
Published: (2021)